目的:探讨精细化管理在肝移植患者术后早期实施目标导向液体疗法的护理策略。方法:选取2019年1月至2023年12月入我科治疗的33例肝移植术后出现低血容量患者的资料,术后均采取目标导向液体疗法,观察患者的血流动力学参数,实施精细化的管...目的:探讨精细化管理在肝移植患者术后早期实施目标导向液体疗法的护理策略。方法:选取2019年1月至2023年12月入我科治疗的33例肝移植术后出现低血容量患者的资料,术后均采取目标导向液体疗法,观察患者的血流动力学参数,实施精细化的管理。结果:33例患者均达到最佳循环功能状态,无严重并发症发生。结论:肝移植术后实施精细化管理对早期实施目标导向液体疗法,减少并发症的发生有较好的作用。Objective: To explore the nursing strategies of refined management in the implementation of goal-directed fluid therapy in the early postoperative period of liver transplantation patients. Methods: Data from 33 liver transplant patients with hypovolemia who were treated in our department from January 2019 to December 2023 were selected. All patients received goal-directed fluid therapy after surgery, and their hemodynamic parameters were observed while implementing refined management. Results: All 33 patients achieved the optimal state of circulatory function without severe complications. Conclusion: The implementation of refined management after liver transplantation has a positive effect on the early application of goal-directed fluid therapy to reduce the incidence of complications.展开更多
目的:探讨肾移植术后合并纯红细胞再生障碍性贫血(Pure red cell aplasia, PRCA)的治疗策略。方法:通过1例肾移植术后发生PRCA的病例的回顾性分析。45岁女性1例,肾移植术后3月出现难治性贫血,骨髓穿刺病理提示纯红细胞再生障碍性贫血,...目的:探讨肾移植术后合并纯红细胞再生障碍性贫血(Pure red cell aplasia, PRCA)的治疗策略。方法:通过1例肾移植术后发生PRCA的病例的回顾性分析。45岁女性1例,肾移植术后3月出现难治性贫血,骨髓穿刺病理提示纯红细胞再生障碍性贫血,经过调整免疫抑制剂、抗病毒治疗、补充重组人促红素(EPO)等治疗贫血无改善,需要反复输血。移植肾失功后进行维持性血液透析,使用足量罗沙司他治疗。结果:经过治疗,患者的贫血得以纠正。结论:肾移植术后发生纯红细胞再生障碍性贫血,可能存在多个诱发因素,如常规治疗无效,罗沙司他可以作为肾移植术后纯红细胞再生障碍性贫血的新选择。展开更多
文摘目的:探讨精细化管理在肝移植患者术后早期实施目标导向液体疗法的护理策略。方法:选取2019年1月至2023年12月入我科治疗的33例肝移植术后出现低血容量患者的资料,术后均采取目标导向液体疗法,观察患者的血流动力学参数,实施精细化的管理。结果:33例患者均达到最佳循环功能状态,无严重并发症发生。结论:肝移植术后实施精细化管理对早期实施目标导向液体疗法,减少并发症的发生有较好的作用。Objective: To explore the nursing strategies of refined management in the implementation of goal-directed fluid therapy in the early postoperative period of liver transplantation patients. Methods: Data from 33 liver transplant patients with hypovolemia who were treated in our department from January 2019 to December 2023 were selected. All patients received goal-directed fluid therapy after surgery, and their hemodynamic parameters were observed while implementing refined management. Results: All 33 patients achieved the optimal state of circulatory function without severe complications. Conclusion: The implementation of refined management after liver transplantation has a positive effect on the early application of goal-directed fluid therapy to reduce the incidence of complications.
文摘目的:探讨肾移植术后合并纯红细胞再生障碍性贫血(Pure red cell aplasia, PRCA)的治疗策略。方法:通过1例肾移植术后发生PRCA的病例的回顾性分析。45岁女性1例,肾移植术后3月出现难治性贫血,骨髓穿刺病理提示纯红细胞再生障碍性贫血,经过调整免疫抑制剂、抗病毒治疗、补充重组人促红素(EPO)等治疗贫血无改善,需要反复输血。移植肾失功后进行维持性血液透析,使用足量罗沙司他治疗。结果:经过治疗,患者的贫血得以纠正。结论:肾移植术后发生纯红细胞再生障碍性贫血,可能存在多个诱发因素,如常规治疗无效,罗沙司他可以作为肾移植术后纯红细胞再生障碍性贫血的新选择。
